SIV-induced terminally differentiated adaptive NK cells in lymph nodes associated with enhanced MHC-E restricted activity.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 02 2021
Historique:
received: 27 08 2020
accepted: 27 01 2021
entrez: 25 2 2021
pubmed: 26 2 2021
medline: 4 3 2021
Statut: epublish

Résumé

Natural killer (NK) cells play a critical understudied role during HIV infection in tissues. In a natural host of SIV, the African green monkey (AGM), NK cells mediate a strong control of SIVagm infection in secondary lymphoid tissues. We demonstrate that SIVagm infection induces the expansion of terminally differentiated NKG2a

Identifiants

pubmed: 33627642
doi: 10.1038/s41467-021-21402-1
pii: 10.1038/s41467-021-21402-1
pmc: PMC7904927
doi:

Substances chimiques

Klrc2 protein, mouse 0
NK Cell Lectin-Like Receptor Subfamily C 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1282

Subventions

Organisme : NIH HHS
ID : P51 OD011132
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI116379
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI143457
Pays : United States
Organisme : NIH HHS
ID : U42 OD011023
Pays : United States

Références

Martin, M. P. & Carrington, M. Immunogenetics of HIV disease. Immunol. Rev. 254, 245–264 (2013).
pubmed: 23772624 pmcid: 3703621 doi: 10.1111/imr.12071
Alter, G. & Altfeld, M. NK cells in HIV-1 infection: Evidence for their role in the control of HIV-1 infection. J. Intern. Med. 265, 29–42 (2009).
pubmed: 19093958 pmcid: 2842208 doi: 10.1111/j.1365-2796.2008.02045.x
Goulder, P. J. R. & Watkins, D. I. Impact of MHC class I diversity on immune control of immunodeficiency virus replication. Nat. Rev. Immunol. 8, 619–630 (2008).
pubmed: 18617886 pmcid: 2963026 doi: 10.1038/nri2357
Freud, A. G., Mundy-Bosse, B. L., Yu, J. & Caligiuri, M. A. The broad spectrum of human natural killer cell diversity. Immunity 47, 820–833 (2017).
pubmed: 29166586 pmcid: 5728700 doi: 10.1016/j.immuni.2017.10.008
Goodridge, J. P., Önfelt, B. & Malmberg, K.-J. Newtonian cell interactions shape natural killer cell education. Immunol. Rev. 267, 197–213 (2015).
pubmed: 26284479 pmcid: 4832384 doi: 10.1111/imr.12325
Blish, C. A. Natural killer cell diversity in viral infection: why and how much? Pathog. Immun. 1, 165–192 (2016).
pubmed: 27635417 pmcid: 5021221 doi: 10.20411/pai.v1i1.142
Strauss-Albee, D. M. et al. Human NK cell repertoire diversity reflects immune experience and correlates with viral susceptibility. Sci. Transl. Med. 7, 297ra115 (2015).
pubmed: 26203083 pmcid: 4547537 doi: 10.1126/scitranslmed.aac5722
Palgen, J.-L. et al. NK cell immune responses differ after prime and boost vaccination. J. Leukoc. Biol. 105, 1055–1073 (2019).
pubmed: 30794328 doi: 10.1002/JLB.4A1018-391RR
Reeves, R. K. et al. Antigen-specific NK cell memory in rhesus macaques. Nat. Immunol. 16, 927–932 (2015).
pubmed: 26193080 pmcid: 4545390 doi: 10.1038/ni.3227
Paust, S., Senman, B. & von Andrian, U. H. Adaptive immune responses mediated by natural killer cells. Immunol. Rev. 235, 286–296 (2010).
pubmed: 20536570 pmcid: 2911633 doi: 10.1111/j.0105-2896.2010.00906.x
Peng, H. & Tian, Z. Natural killer cell memory: progress and implications. Front. Immunol. 8, 1143 (2017).
pubmed: 28955346 pmcid: 5601391 doi: 10.3389/fimmu.2017.01143
Lucar, O., Reeves, R. K. & Jost, S. A natural impact: NK cells at the intersection of cancer and HIV disease. Front. Immunol. 10, 1850 (2019).
Luteijn, R. et al. Early viral replication in lymph nodes provides HIV with a means by which to escape NK-cell-mediated control. Eur. J. Immunol. 41, 2729–2740 (2011).
pubmed: 21630248 doi: 10.1002/eji.201040886 pmcid: 8943700
Schafer, J. L., Li, H., Evans, T. I., Estes, J. D. & Reeves, R. K. Accumulation of cytotoxic CD16+ NK cells in simian immunodeficiency virus-infected lymph nodes associated with in situ differentiation and functional anergy. J. Virol. 89, 6887–6894 (2015).
pubmed: 25903330 pmcid: 4468491 doi: 10.1128/JVI.00660-15
Freud, A. G. et al. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 22, 295–304 (2005).
pubmed: 15780987 doi: 10.1016/j.immuni.2005.01.013
Svardal, H. et al. Ancient hybridization and strong adaptation to viruses across African vervet monkey populations. Nat. Genet. 49, 1705–1713 (2017).
pubmed: 29083404 pmcid: 5709169 doi: 10.1038/ng.3980
Müller, M. C. et al. Simian immunodeficiency viruses from central and western Africa: evidence for a new species-specific lentivirus in tantalus monkeys. J. Virol. 67, 1227–1235 (1993).
pubmed: 8437214 pmcid: 237488 doi: 10.1128/jvi.67.3.1227-1235.1993
Raehtz, K., Pandrea, I. & Apetrei, C. The well-tempered SIV infection: pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression. Infect. Genet. Evol. 46, 308–323 (2016).
pubmed: 27394696 pmcid: 5360191 doi: 10.1016/j.meegid.2016.07.006
Sodora, D. L. et al. Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts. Nat. Med. 15, 861–865 (2009).
pubmed: 19661993 pmcid: 2782707 doi: 10.1038/nm.2013
Huot, N. et al. Natural killer cells migrate into and control simian immunodeficiency virus replication in lymph node follicles in African green monkeys. Nat. Med. 23, 1277–1286 (2017).
pubmed: 29035370 pmcid: 6362838 doi: 10.1038/nm.4421
Hong, J. J., Chang, K.-T. & Villinger, F. The dynamics of T and B cells in lymph node during chronic HIV infection: TFH and HIV, unhappy dance partners? Front. Immunol. 7, 522 (2016).
Wong, J. K. & Yukl, S. A. Tissue reservoirs of HIV. Curr. Opin. HIV AIDS 11, 362–370 (2016).
pubmed: 27259045
Strauss-Albee, D. M., Horowitz, A., Parham, P. & Blish, C. A. Coordinated regulation of NK receptor expression in the maturing human immune system. J. Immunol. 193, 4871–4879 (2014).
pubmed: 25288567 doi: 10.4049/jimmunol.1401821
Horowitz, A. et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci. Transl. Med. 5, 208ra145 (2013).
pubmed: 24154599 pmcid: 3918221 doi: 10.1126/scitranslmed.3006702
Victor, A. R. et al. Epigenetic and post-transcriptional regulation of CD16 expression during human natural killer cell development. J. Immunol. 200, 565–572 (2018).
pubmed: 29229679 doi: 10.4049/jimmunol.1701128
Sivori, S. et al. TLR/NCR/KIR: which one to use and when? Front. Immunol. 5, 105 (2014).
pubmed: 24678311 pmcid: 3958761 doi: 10.3389/fimmu.2014.00105
Jeevan-Raj, B. et al. The transcription factor Tcf1 contributes to normal NK cell development and function by limiting the expression of granzymes. Cell Rep. 20, 613–626 (2017).
pubmed: 28723565 doi: 10.1016/j.celrep.2017.06.071
Goh, W. & Huntington, N. D. Regulation of murine natural killer cell development. Front. Immunol. 8, 130 (2017).
Béziat, V., Descours, B., Parizot, C., Debré, P. & Vieillard, V. NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS ONE 5, e11966 (2010).
Luetke-Eversloh, M., Killig, M. & Romagnani, C. Signatures of human NK cell development and terminal differentiation. Front. Immunol. 4, 499 (2013).
pubmed: 24416035 pmcid: 3874559 doi: 10.3389/fimmu.2013.00499
Freud, A. G., Yu, J. & Caligiuri, M. A. Human natural killer cell development in secondary lymphoid tissues. Semin. Immunol. 26, 132–137 (2014).
pubmed: 24661538 pmcid: 4010312 doi: 10.1016/j.smim.2014.02.008
O’Sullivan, T. E., Johnson, L. R., Kang, H. H. & Sun, J. C. BNIP3- and BNIP3L-mediated mitophagy promotes the generation of natural killer cell memory. Immunity 43, 331–342 (2015).
pubmed: 26253785 pmcid: 5737626 doi: 10.1016/j.immuni.2015.07.012
Evavold, C. L. & Kagan, J. C. How Inflammasomes Inform Adaptive Immunity. J. Mol. Biol. 430, 217–237 (2018).
pubmed: 28987733 doi: 10.1016/j.jmb.2017.09.019
van den Boorn, J. G. et al. Inflammasome-dependent induction of adaptive NK cell memory. Immunity 44, 1406–1421 (2016).
pubmed: 27287410 doi: 10.1016/j.immuni.2016.05.008
Paust, S., Blish, C. A. & Reeves, R. K. Redefining memory: building the case for adaptive NK cells. J. Virol. 91, e00169-17 (2017).
Cichocki, F., Miller, J. S., Anderson, S. K. & Bryceson, Y. T. Epigenetic regulation of NK cell differentiation and effector functions. Front. Immunol. 4, 55 (2013).
Tesi, B., Schlums, H., Cichocki, F. & Bryceson, Y. T. Epigenetic regulation of adaptive NK cell diversification. Trends Immunol. 37, 451–461 (2016).
pubmed: 27160662 doi: 10.1016/j.it.2016.04.006
Wagner, J. A. & Fehniger, T. A. Human adaptive natural killer cells: beyond NKG2C. Trends Immunol. 37, 351–353 (2016).
pubmed: 27179621 pmcid: 4885776 doi: 10.1016/j.it.2016.05.001
Anfossi, N. et al. Human NK cell education by inhibitory receptors for MHC class I. Immunity 25, 331–342 (2006).
pubmed: 16901727 doi: 10.1016/j.immuni.2006.06.013
Zhang, X., Feng, J., Chen, S., Yang, H. & Dong, Z. Synergized regulation of NK cell education by NKG2A and specific Ly49 family members. Nat. Commun. 10, 1–12 (2019).
He, Y. & Tian, Z. NK cell education via nonclassical MHC and non-MHC ligands. Cell. Mol. Immunol. 14, 321–330 (2017).
pubmed: 27264685 doi: 10.1038/cmi.2016.26
Braud, V. M., Allan, D. S. J., Wilson, D. & McMichael, A. J. TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide. Curr. Biol. 8, 1–10 (1998).
pubmed: 9427624 doi: 10.1016/S0960-9822(98)70014-4
Michaëlsson, J. et al. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J. Exp. Med. 196, 1403–1414 (2002).
pubmed: 12461076 pmcid: 2194258 doi: 10.1084/jem.20020797
Pietra, G. et al. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. Proc. Natl Acad. Sci. USA 100, 10896–10901 (2003).
pubmed: 12960383 doi: 10.1073/pnas.1834449100 pmcid: 196899
Schulte, D. et al. The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cells. J. Infect. Dis. 200, 1397–1401 (2009).
pubmed: 19780673 doi: 10.1086/605889
Rölle, A., Jäger, D. & Momburg, F. HLA-E peptide repertoire and dimorphism—centerpieces in the adaptive NK cell puzzle? Front. Immunol. 9, 2410 (2018).
Walters, L. C. et al. Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding. Nat. Commun. 9, 3137 (2018).
pubmed: 30087334 pmcid: 6081459 doi: 10.1038/s41467-018-05459-z
Hansen, S. G. et al. Broadly targeted CD8+ T cell responses restricted by major histocompatibility complex E. Science 351, 714–720 (2016).
pubmed: 26797147 pmcid: 4769032 doi: 10.1126/science.aac9475
Asmal, M. et al. A signature in HIV-1 envelope leader peptide associated with transition from acute to chronic infection impacts envelope processing and infectivity. PLoS ONE 6, e23673 (2011).
da Silva, J. X. et al. Sequence variations of Env signal peptide alleles in different clinical stages of HIV infection. Peptides 32, 1800–1806 (2011).
pubmed: 21816188 doi: 10.1016/j.peptides.2011.07.014
Yolitz, J. et al. Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120. Proc. Natl Acad. Sci. USA 115, 2443–2448 (2018).
pubmed: 29463753 doi: 10.1073/pnas.1722627115 pmcid: 5877976
Huot, N., Bosinger, S. E., Paiardini, M., Reeves, R. K. & Müller-Trutwin, M. Lymph node cellular and viral dynamics in natural hosts and impact for HIV cure strategies. Front. Immunol. 9, 780 (2018).
pubmed: 29725327 pmcid: 5916971 doi: 10.3389/fimmu.2018.00780
Jacquelin, B. et al. Innate immune responses and rapid control of inflammation in african green monkeys treated or not with interferon-alpha during primary SIVagm infection. PLoS Pathog. 10, e1004241 (2014).
Schlums, H. et al. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 42, 443–456 (2015).
pubmed: 25786176 pmcid: 4612277 doi: 10.1016/j.immuni.2015.02.008
Cichicki, F. et al. Diversification and functional specialization of human NK cell subsets. Curr. Top. Microbiol. Immunol. 395, 63–94 (2016).
pubmed: 26472216
Wilk, A. J. & Blish, C. A. Diversification of human NK cells: Lessons from deep profiling. J. Leukoc. Biol. 103, 629–641 (2018).
pubmed: 29350874 doi: 10.1002/JLB.6RI0917-390R
Romee, R. et al. NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17). Blood 121, 3599–3608 (2013).
pubmed: 23487023 pmcid: 3643761 doi: 10.1182/blood-2012-04-425397
Kristensen, A. B., Kent, S. J. & Parsons, M. S. Contribution of NK cell education to both direct and anti-HIV-1 antibody-dependent NK cell functions. J. Virol. 92, e02146-17 (2018).
Rasid, O. et al. H3K4me1 supports memory-like NK cells induced by systemic inflammation. Cell Rep. 29, 3933–3945.e3 (2019).
pubmed: 31851924 doi: 10.1016/j.celrep.2019.11.043
Wu, Y., Tian, Z. & Wei, H. Developmental and functional control of natural killer cells by cytokines. Front. Immunol. 8, 930 (2017).
Wang, Y. et al. HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cells. Nat. Immunol. 21, 274–286 (2020).
pubmed: 32066947 pmcid: 7044076 doi: 10.1038/s41590-020-0593-9
Yang, I. et al. Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme. J. Neurosurg. 100, 310–319 (2004).
pubmed: 15086239 doi: 10.3171/jns.2004.100.2.0310
Zhou, F. Molecular mechanisms of IFN-γ to up-regulate MHC class I antigen processing and presentation. Int. Rev. Immunol. 28, 239–260 (2009).
pubmed: 19811323 doi: 10.1080/08830180902978120
Kornfeld, C. et al. Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J. Clin. Invest. 115, 1389–1389 (2005).
pmcid: 1087160
Nguyen, S. et al. HLA-E upregulation on IFN-γ-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT. Bone Marrow Transplant. 43, 693–699 (2009).
pubmed: 19011664 doi: 10.1038/bmt.2008.380
Ploquin, M. J.-Y. et al. Distinct expression profiles of TGF-β1 signaling mediators in pathogenic SIVmac and non-pathogenic SIVagm infections. Retrovirology 3, 37 (2006).
pubmed: 16800882 pmcid: 1533859 doi: 10.1186/1742-4690-3-37
Ramsuran, V. et al. Elevated HLA-A expression impairs HIV control through inhibition of NKG2A-expressing cells. Science 359, 86–90 (2018).
pubmed: 29302013 pmcid: 5933048 doi: 10.1126/science.aam8825
Miller, J. D. et al. Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2. J. Immunol. 171, 1369–1375 (2003).
pubmed: 12874227 doi: 10.4049/jimmunol.171.3.1369
Celik, A. A., Kraemer, T., Huyton, T., Blasczyk, R. & Bade-Döding, C. The diversity of the HLA-E-restricted peptide repertoire explains the immunological impact of the Arg107Gly mismatch. Immunogenetics 68, 29–41 (2016).
pubmed: 26552660 doi: 10.1007/s00251-015-0880-z
Hannoun, Z. et al. Identification of novel HIV-1-derived HLA-E-binding peptides. Immunol. Lett. 202, 65–72 (2018).
pubmed: 30172717 pmcid: 6291738 doi: 10.1016/j.imlet.2018.08.005
Joosten, S. A., Sullivan, L. C. & Ottenhoff, T. H. M. Characteristics of HLA-E restricted T-cell responses and their role in infectious diseases. J. Immunol. Res. 2016, 2695396 (2016).
Hammer, Q. et al. Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells. Nat. Immunol. 19, 453–463 (2018).
pubmed: 29632329 doi: 10.1038/s41590-018-0082-6
Malmberg, K.-J., Beziat, V. & Ljunggren, H.-G. Spotlight on NKG2C and the human NK-cell response to CMV infection. Eur. J. Immunol. 42, 3141–3145 (2012).
pubmed: 23255011 doi: 10.1002/eji.201243050
Pupuleku, A. et al. Elusive role of the CD94/NKG2C NK cell receptor in the response to cytomegalovirus: novel experimental observations in a reporter cell system. Front. Immunol. 8, 1317 (2017).
Béziat, V. et al. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 42, 447–457 (2012).
pubmed: 22105371 doi: 10.1002/eji.201141826
Brockmeyer, C. et al. T cell receptor (TCR)-induced tyrosine phosphorylation dynamics identifies THEMIS as a new TCR signalosome component. J. Biol. Chem. 286, 7535–7547 (2011).
pubmed: 21189249 doi: 10.1074/jbc.M110.201236
Paster, W. et al. GRB2-mediated recruitment of THEMIS to LAT is essential for thymocyte development. J. Immunol. 190, 3749–3756 (2013).
pubmed: 23460737 pmcid: 3607403 doi: 10.4049/jimmunol.1203389
Choi, S. et al. THEMIS enhances TCR signaling and enables positive selection by selective inhibition of SHP-1. Nat. Immunol. 18, 433–441 (2017).
pubmed: 28250424 pmcid: 5807080 doi: 10.1038/ni.3692
Daskalaki, M. et al. Long-term efficient control of SIV infection in macaques is associated with an intact intestinal barrier. J. Med. Primatol. 46, 144–148 (2017).
pubmed: 28748664 doi: 10.1111/jmp.12294
Ram, D. R. et al. Tracking KLRC2 (NKG2C)+ memory-like NK cells in SIV+ and rhCMV+ rhesus macaques. PLoS Pathog. 14, e1007104 (2018).
pubmed: 29851983 pmcid: 5997355 doi: 10.1371/journal.ppat.1007104
Jacquelin, B. et al. Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response. J. Clin. Invest. 119, 3544–3555 (2009).
pubmed: 19959873 pmcid: 2786805
Mussil, B., Sauermann, U., Motzkus, D., Stahl-Hennig, C. & Sopper, S. Increased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys. Retrovirology 8, 77 (2011).
pubmed: 21955401 pmcid: 3192745 doi: 10.1186/1742-4690-8-77
Gnanadurai, C. W. et al. Genetic identity and biological phenotype of a transmitted/founder virus representative of nonpathogenic simian immunodeficiency virus infection in african green monkeys. J. Virol. 84, 12245–12254 (2010).
pubmed: 20881048 pmcid: 2976391 doi: 10.1128/JVI.01603-10
Diop, O. M. et al. High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys. J. Virol. 74, 7538–7547 (2000).
pubmed: 10906207 pmcid: 112274 doi: 10.1128/JVI.74.16.7538-7547.2000
Nielsen, M. et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci. Publ. Protein Soc. 12, 1007–1017 (2003).
doi: 10.1110/ps.0239403
Lundegaard, C., Lund, O. & Nielsen, M. Accurate approximation method for prediction of class I MHC affinities for peptides of length 8, 10 and 11 using prediction tools trained on 9mers. Bioinformatics 24, 1397–1398 (2008).
pubmed: 18413329 doi: 10.1093/bioinformatics/btn128
Wu, H. L. et al. The role of MHC-E in T cell immunity is conserved among humans, rhesus macaques, and cynomolgus macaques. J. Immunol. 200, 49–60 (2018).
pubmed: 29150562 doi: 10.4049/jimmunol.1700841
Alter, G., Malenfant, J. M. & Altfeld, M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods. 294, 15–22 https://doi.org/10.1016/j.jim.2004.08.008 (2004). PMID: 15604012.
doi: 10.1016/j.jim.2004.08.008 pubmed: 15604012
Aktas, E., Kucuksezer, U. C., Bilgic, S., Erten, G. & Deniz, G. Relationship between CD107a expression and cytotoxic activity. Cell Immunol. 254, 149–154 https://doi.org/10.1016/j.cellimm.2008.08.007 (2009). Epub 2008 Oct 5. PMID: 18835598.
doi: 10.1016/j.cellimm.2008.08.007 pubmed: 18835598
Webb, B. & Sali, A. Protein structure modeling with MODELLER. Methods Mol. Biol. 1137, 1–15 (2014).
pubmed: 24573470 doi: 10.1007/978-1-4939-0366-5_1
Ashkenazy, H. et al. ConSurf 2016: an improved methodology to estimate and visualize evolutionary conservation in macromolecules. Nucleic Acids Res. 44, W344–W350 (2016).
pubmed: 27166375 pmcid: 4987940 doi: 10.1093/nar/gkw408
Cokelaer, T., Desvillechabrol, D., Legendre, R. & Cardon, M. ‘Sequana’: a Set of Snakemake NGS pipelines. J. Open Source Softw. 2, 352 (2017).
doi: 10.21105/joss.00352
Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923–930 (2014).
pubmed: 24227677 doi: 10.1093/bioinformatics/btt656
Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).
pubmed: 25516281 pmcid: 4302049 doi: 10.1186/s13059-014-0550-8
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B Methodol. 57, 289–300 (1995).
Bindea, G. et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25, 1091–1093 (2009).
pubmed: 19237447 pmcid: 2666812 doi: 10.1093/bioinformatics/btp101

Auteurs

Nicolas Huot (N)

Institut Pasteur, Unité HIV, Inflammation et Persistance, Paris, France.

Philippe Rascle (P)

Institut Pasteur, Unité HIV, Inflammation et Persistance, Paris, France.
Université Paris Diderot, Sorbonne Paris Cité, Paris, France.

Caroline Petitdemange (C)

Institut Pasteur, Unité HIV, Inflammation et Persistance, Paris, France.

Vanessa Contreras (V)

CEA-Université Paris Sud-Inserm, U1184, IDMIT Department, IBFJ, Fontenay-aux-Roses, France.

Christina M Stürzel (CM)

Ulm University Medical Center, Ulm, Germany.

Eduard Baquero (E)

Institut Pasteur, Unité de Virologie Structurale, Paris, France.

Justin L Harper (JL)

Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.

Caroline Passaes (C)

Institut Pasteur, Unité HIV, Inflammation et Persistance, Paris, France.

Rachel Legendre (R)

Bioinformatics and Biostatistics Hub, Department of Computational Biology, Institut Pasteur, Paris, France.

Hugo Varet (H)

Biomics Platform, Center for Technological Resources and Research (C2RT), Institut Pasteur, Paris, France.

Yoann Madec (Y)

Institut Pasteur; Epidemiology of Emerging Diseases Unit, Paris, France.

Ulrike Sauermann (U)

Deutsches Primatenzentrum - Leibniz Institut für Primatenforschung, Göttingen, Germany.

Christiane Stahl-Hennig (C)

Deutsches Primatenzentrum - Leibniz Institut für Primatenforschung, Göttingen, Germany.

Jacob Nattermann (J)

Medizinische Klinik und Poliklinik I, Universitätsklinikum Bonn, Germany; German Center for Infection Research (DZIF), Bonn, Germany.

Asier Saez-Cirion (A)

Institut Pasteur, Unité HIV, Inflammation et Persistance, Paris, France.

Roger Le Grand (R)

CEA-Université Paris Sud-Inserm, U1184, IDMIT Department, IBFJ, Fontenay-aux-Roses, France.

R Keith Reeves (R)

Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.

Mirko Paiardini (M)

Division of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA, USA.
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA, USA.

Frank Kirchhoff (F)

Ulm University Medical Center, Ulm, Germany.

Beatrice Jacquelin (B)

Institut Pasteur, Unité HIV, Inflammation et Persistance, Paris, France.

Michaela Müller-Trutwin (M)

Institut Pasteur, Unité HIV, Inflammation et Persistance, Paris, France. mmuller@pasteur.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH